Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
BACKGROUND: Primaquine is the only licensed antimalarial for the radical cure of Plasmodium vivax infections. Many countries, however, do not administer primaquine due to fear of hemolysis in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In other settings, primaquine is given witho...
Główni autorzy: | Devine, A, Parmiter, M, Chu, C, Bancone, G, Nosten, F, Price, R, Lubell, Y, Yeung, S |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
Public Library of Science
2017
|
Podobne zapisy
-
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
od: Angela Devine, i wsp.
Wydane: (2017-05-01) -
A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border
od: Ansari, AT, i wsp.
Wydane: (2025) -
A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border
od: April T. Ansari, i wsp.
Wydane: (2025-01-01) -
A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border.
od: April T Ansari, i wsp.
Wydane: (2025-01-01) -
Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar.
od: Yuan, L, i wsp.
Wydane: (2014)